SecBot SecBot
Insider Cluster (5 insiders) ·Filed Sep 2, 2026

OCUL

OCULAR THERAPEUTIX, INC
NEUTRAL
Impact 4/10
Horizonweeks Processed2mo ago
Insider cluster: 5 insiders, $0.3M total
Actionable Insight • Neutral

The cluster is small in dollar terms but involves multiple C-suite executives selling on the same day, which is atypical for routine diversification. Monitor for any upcoming pipeline data readouts or regulatory updates that could explain the timing.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$10.64
T+0 close · Sep 2, 2026 · via day close
Latest settled
−34.59%
T+20 · $6.96 · next T+60 in 13d
Vs SPY
−34.38%
α at T+20
Latest observation
−34.61%
T+50 · FF3 residual α
  1. T+0 · Sep 3 $10.64entry
  2. T+1 · 2mo ago 0.00%α +0.39% · $10.64
  3. T+5 · 2mo ago −1.41%α −0.26% · $10.49
  4. T+20 · 7w ago −34.59%α −34.38% · $6.96
  5. T+51 · todayOpen
  6. T+60 · in 13d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Five senior executives at Ocular Therapeutix, including the Chief Scientific Officer, Chief Operating Officer, and Chief Development Officer, sold a total of ~$333K in shares over a one-week period. While the dollar amount is modest relative to the $2.4B market cap (0.01%), the cluster involves multiple C-suite insiders selling on the same day, which warrants attention despite the academic literature showing cluster sales are less informative than buys. The sales follow a strong recent stock performance and occur ahead of potential pipeline catalysts for the company's lead drug candidate.

Key Financial Metrics

Direction
selling
Total Value
$333.0K
Insiders
5

Key Facts

  • Five insiders sold shares totaling ~$333K from Aug 24-31, 2026
  • Sales include CSO, COO, Chief Development Officer, Chief Strategy Officer, and a senior executive
  • All sales were open-market transactions at prices between $10.24-$10.78
  • Total sales represent ~0.01% of OCUL's $2.4B market cap
  • No insider purchases were reported in the cluster window

Financial Impact

~$333K in insider sales, representing 0.01% of market cap

insider ownership

Risk Factors

  • Insider sales may signal management caution ahead of pipeline milestones
  • No insider buying to offset the selling cluster

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-OCUL-1788412176966

Track record

20 reports on OCUL

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +24.88% at T+20 after the Aug 3, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 10, 20266d ago 3 Neutral 2/10 Entry $6.66 Now $6.01 −9.76% settles Nov 18
  2. Nov 9, 20267d ago 8-K Neutral 2/10 Entry $6.85 to $6.01 Now $6.01 −12.26% ▼ −12.26% −10.57% vs SPY
  3. Nov 9, 20267d ago Press Release Bearish 5/10 Entry $6.85 to $6.01 Now $6.01 +12.26% ▲ +12.26% +10.57% vs SPY
  4. Nov 5, 202611d ago 144 Neutral 3/10 Entry $6.60 to $6.21 Now $6.01 −8.87% ▼ −5.84% −8.43% vs SPY
  5. Oct 16, 20264w ago 8-K Neutral 2/10 Entry $6.29 to $6.47 Now $6.01 −4.45% ▲ +2.86% +3.01% vs SPY
  6. Oct 8, 20265w ago 144 Neutral 2/10 Entry $7.54 to $6.87 Now $6.01 −20.29% ▼ −8.89% −6.92% vs SPY
  7. Sep 2, 202610w ago Insider Cluster Neutral 4/10 Viewing Entry $10.64 to $10.49 Now $6.01 −43.52% ▼ −1.41% −0.26% vs SPY
  8. Aug 26, 202611w ago Insider Cluster Neutral 3/10 Entry $10.82 to $10.64 Now $6.01 −44.45% ▼ −1.66% −1.93% vs SPY
  9. Aug 3, 202615w ago 8-K Bullish 7/10 Entry $8.40 to $9.24 Now $6.01 −28.45% ▲ +10.00% +7.97% vs SPY
  10. Jun 17, 202621w ago Press Release Bullish 6/10 Entry $9.64 to $9.85 Now $6.01 −37.66% ▲ +2.18% +3.22% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 8h 53m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 3, 2026